Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
Does Insurance Cover Zepbound for Sleep Apnea? 2026 Guide
By The RX Index Editorial Team ·
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This guide is educational and is not medical, legal, or insurance advice. We may earn a commission if you use some provider links below. That never changes the coverage rules, prices, or source documents we show you.
Does insurance cover Zepbound for sleep apnea? Often, yes — but almost never automatically.
Some commercial plans and Medicare Part D plans can cover Zepbound (tirzepatide) when it's prescribed for the condition the FDA approved it for: moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. The catch lives in the fine print. Your plan has to list it, you'll need a sleep study and a prior authorization, and the request has to be filed as sleep apnea treatment — not weight loss.
Quick answer by your situation
| Your situation | Is coverage possible? | Your first move |
|---|---|---|
| Commercial/employer plan + OSA diagnosis + BMI 30+ | Often yes — depends on your plan | Check your drug list, file an OSA-specific prior auth |
| Federal employee (FEHB) plan | Often yes, plan-dependent | Run a free coverage check, then file the PA |
| Medicare Part D, prescribed for OSA | Yes — through regular Part D (not the new $50 Bridge) | Ask your plan if it's covered for OSA |
| Denied as a “weight-loss drug” | Often fixable — unless it's a hard plan exclusion | Match the denial reason to the missing document |
| No sleep study yet | Not ready for a prior auth | Ask your doctor about a sleep study |
| Plan excludes obesity meds entirely | Maybe — depends if the exclusion also blocks the OSA path | Ask for the written exclusion; if there's no exception, compare self-pay |
Have commercial or federal-employee (FEHB) insurance?
The fastest way to stop guessing is a free coverage check. Ro's free GLP-1 Insurance Coverage Checker uses your insurance info to contact your insurer and send back a personalized coverage report — including whether prior authorization is required. If you later join Ro and a Ro-affiliated provider approves treatment, Ro says its insurance team gets the coverage process started for you.
Check your Zepbound coverage free with Ro → (sponsored affiliate link, opens in a new tab)On Medicare or Medicaid? Skip to the Medicare section — Ro can't coordinate government coverage (except FEHB), and you have a different, better path.
Does insurance cover Zepbound for sleep apnea?
Think of coverage as four gates, all of which have to line up:
Your plan lists the drug. If Zepbound isn't on your formulary (your plan's list of covered drugs), you'll need a formulary exception.
Your diagnosis qualifies. Moderate-to-severe OSA, in an adult with obesity.
Your documents prove it. A sleep study and a current BMI are the big two.
The request is filed for sleep apnea. Not "weight loss" -- this is where most people quietly lose.
Coverage is most likely when you have a sleep study showing moderate-to-severe OSA, a BMI of 30 or higher, and a doctor's office that submits the prior authorization under the sleep apnea indication with the right chart notes. Coverage is least likely when the prescription goes in as weight loss only, there's no sleep study attached, the OSA is mild rather than moderate-to-severe, or the plan has a hard exclusion with no medical exception.
Is Zepbound really FDA-approved for sleep apnea — and does it work?
The trial that earned the approval, SURMOUNT-OSA, ran two 52-week studies in adults with moderate-to-severe OSA and a BMI of 30 or higher. Here's what it found, straight from Eli Lilly's clinical data:
| SURMOUNT-OSA result (52 weeks) | Study 1 — not using CPAP | Study 2 — using CPAP |
|---|---|---|
| Drop in AHI (breathing events/hour) on Zepbound | 25.3 fewer events/hour | 29.3 fewer events/hour |
| Drop in AHI on placebo | 5.3 fewer events/hour | 5.5 fewer events/hour |
| Percent reduction in AHI on Zepbound | 50.7% | 58.7% |
| Reached remission or mild, non-symptomatic OSA | 42.2% (vs 15.9% on placebo) | 50.2% (vs 14.3% on placebo) |
| Source: Eli Lilly; results published in the New England Journal of Medicine. | ||
In plain terms: the AHI is the number of times your breathing stops or gets shallow each hour of sleep — it's how doctors grade sleep apnea. People on Zepbound cut that number by about half, and roughly four to five out of ten reached remission or mild OSA, versus about one and a half out of ten on placebo.
Will commercial insurance cover Zepbound for sleep apnea?
UnitedHealthcare publishes a specific “Zepbound — Obstructive Sleep Apnea Only” prior-authorization policy that allows coverage of Zepbound for obesity with OSA even on plans where weight-loss drugs otherwise aren't covered. CVS Caremark and Aetna have their own OSA criteria built around the same core proof. The lesson is simple: the words on your prior authorization matter as much as your diagnosis.
The denial trap: “weight loss” vs. “sleep apnea”
This is the single most common way people lose.
Your doctor prescribes Zepbound, the request gets processed as a weight-loss medication, your plan excludes weight-loss meds, and you get an automatic “no” — even though you have a real, documented sleep apnea diagnosis your plan might actually cover. The fix isn't to give up. It's to make sure the request is submitted under the OSA indication, with the sleep study attached.
One honest note: if your specific employer plan has a hard exclusion on all anti-obesity medications with no medical-necessity exception, an appeal may go nowhere, no matter how clean your paperwork is. That's a real wall. But if your denial happened because the request was treated as “weight loss” instead of documented moderate-to-severe sleep apnea, that's not a wall — it's a fixable filing error, and the OSA path is your way through.
The CVS Caremark story (the part that's changing right now)
If you have a CVS Caremark plan, your coverage has been a moving target. Here's the current timeline:
- July 1, 2025: CVS Caremark removed Zepbound from its major commercial drug lists and made Wegovy its preferred GLP-1. The change affected an estimated 200,000 patients and prompted a class-action lawsuit.
- Effective June 1, 2026: CVS Caremark is lifting its “new-to-market” block on Foundayo (Eli Lilly's GLP-1 pill) where plans choose to cover it.
- Effective October 1, 2026: CVS Caremark is adding Zepbound back to its commercial drug lists as an additional preferred option. Plan sponsors still decide whether to cover GLP-1s at all.
(Source: Reuters; Managed Healthcare Executive; CVS Health.) Two takeaways. First, even while Zepbound sat off the weight-loss list, the sleep apnea indication gave many patients a stronger case for a formulary exception — because Wegovy, the preferred alternative, isn't FDA-approved for OSA, so there was no equal substitute to point them to. Second, check your plan's current status before you assume anything.
If your plan covers GLP-1s but you're facing prior authorization, step therapy, or a denial, you don't have to fight the paperwork alone. For commercial and FEHB members, Ro runs a dedicated insurance team that contacts your insurer and, once you're a member and approved for treatment, submits the prior authorization for you.
See if you're covered and let Ro handle the prior authorization → (sponsored affiliate link, opens in a new tab)Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
Membership is $39 first month, then $149/month or as low as $74/month annually. Medication cost is separate.What do major payer policies actually require?
| Plan / PBM | OSA-specific coverage path? | BMI rule | Sleep-study rule | Diet/activity rule | Initial approval | To renew |
|---|---|---|---|---|---|---|
| UnitedHealthcare | Yes — a dedicated “Zepbound — OSA Only” policy that can cover OSA even if weight-loss drugs are excluded | BMI ≥30 | Moderate-to-severe OSA on a sleep study; AHI/REI/RDI ≥15 | Reduced-calorie diet and activity, plus at least one prior weight-loss attempt on record | ~6 months | Show response (improved sleep measures and/or weight) |
| CVS Caremark | Yes — OSA criteria (Zepbound returns to commercial lists Oct 1, 2026) | BMI ≥30 | Moderate-to-severe OSA on PSG or home sleep test; AHI ≥15 | Reduced-calorie diet and increased physical activity documented | ~6 months | ~12 months; requires a positive response / fewer OSA symptoms |
| Aetna | Yes — OSA criteria | BMI ≥30 | Moderate-to-severe OSA on PSG or home sleep test; AHI ≥15 | Reduced-calorie diet and increased physical activity documented | Per policy | Positive response plus maintenance dosing |
What documents do insurers want for a prior authorization?
Your prior authorization checklist
- ✓A sleep study report — either an in-lab polysomnography (PSG) or a home sleep apnea test
- ✓An AHI (or REI/RDI) of at least 15 events per hour — the line between mild and moderate OSA
- ✓A diagnosis of moderate-to-severe OSA — in your chart
- ✓Current height, weight, and BMI — for the OSA path, plans like UnitedHealthcare, CVS Caremark, and Aetna use BMI 30 or higher
- ✓The prescription filed for the OSA indication — the step that prevents the "weight loss" denial
- ✓ICD-10 codes on the claim — G47.33 (obstructive sleep apnea) plus an obesity code such as E66.x
- ✓Documented diet and activity effort — a reduced-calorie diet and more activity; UnitedHealthcare also wants at least one past weight-loss attempt on record
- ✓CPAP/PAP notes if your plan asks — adherence, intolerance, or why you're not a candidate
- ✓A letter of medical necessity — from your prescriber for borderline cases or appeals
Hand this to your doctor
You don't have to be the expert. You just have to ask the right question. Copy this and bring it to your appointment:
“My plan may cover Zepbound when it's prescribed for FDA-approved moderate-to-severe obstructive sleep apnea in an adult with obesity. Can your office submit the prior authorization under the OSA indication and include my sleep study, my AHI, my BMI, my chart notes, and my CPAP history if the plan requires it?”
One thing we won't tell you to do: ask anyone to put down a diagnosis that isn't accurate. You don't need to. If you genuinely have moderate-to-severe OSA and obesity, the request just needs to reflect the condition you're actually being treated for.
Does Medicare cover Zepbound for sleep apnea?
The trap: the Medicare GLP-1 Bridge is NOT the path for sleep apnea
You may have heard about the Medicare GLP-1 Bridge — a program offering Zepbound and Wegovy for a $50 monthly copay, starting and running through . It's real. But the Bridge is for weight loss, not sleep apnea. CMS is clear that when Zepbound is prescribed for OSA, it goes through your regular Part D plan— your normal drug list, prior authorization, and cost-sharing — not the $50 Bridge. (Source: CMS Medicare GLP-1 Bridge guidance.)
| If Zepbound is prescribed for… | Your Medicare route |
|---|---|
| Moderate-to-severe OSA with obesity | Regular Part D — formulary + prior auth (not the Bridge) |
| Weight loss / obesity only | The Medicare GLP-1 Bridge, if you meet the program's criteria ($50/mo) |
| You're not sure why | Ask your prescriber which diagnosis is on the prescription |
On regular Part D, you pay your plan's cost-sharing, but your out-of-pocket on covered Part D drugs is capped at $2,100 for 2026 — though that ceiling only helps if your plan actually covers the drug or approves it through an exception. And manufacturer savings cards don't work with Medicare, Medicaid, TRICARE, or VA coverage — that's federal law. For Medicare, call the number on your plan card and ask: “Is Zepbound on my formulary for obstructive sleep apnea, and what's the prior authorization?” For the full Medicare picture, see our Does Medicare Cover Zepbound guide.
What about Medicaid?
Medicaid is state-by-state. Coverage of GLP-1s for obesity is limited — only a handful of states cover them. But the sleep apnea indication can be treated differently, because Medicaid programs generally cover FDA-approved drugs for their approved uses, subject to the state's rules. So a “no” for weight loss isn't automatically a “no” for OSA. Check your state's Medicaid formulary and prior-authorization rules before assuming either way. (Source: KFF.)
Not sure whether you're in the regular Part D lane, the Bridge lane, or a state Medicaid path? Our free 60-second matching quiz sorts you into the right one.
Get your personalized GLP-1 action plan →How much does Zepbound cost for sleep apnea — with and without insurance?
| Your path | What you'll likely pay per month | The fine print |
|---|---|---|
| Commercial plan covers it + savings card | ~$25/month | Eligibility limits apply; savings card not for government insurance |
| Commercial plan doesn't cover it + savings card | ~$499/month | A pen-based discount; verify current terms at zepbound.lilly.com |
| Self-pay through LillyDirect (sponsored affiliate link, opens in a new tab) (no insurance) | $299–$449/month | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg). For 7.5–15 mg, the $449 price requires the 45-day refill timing; miss it and regular prices apply. |
| Medicare Part D (covered for OSA) | Your plan's cost-sharing | Capped at $2,100 total out-of-pocket in 2026. Savings card not allowed. |
| Single-dose pen / retail | Up to ~$1,086/fill | Hardly anyone pays this — check the savings, insurance, LillyDirect, and exception paths above first. |
The $1,086 list price is rarely what anyone actually pays — there's almost always a cheaper path. And Medicare and Medicaid patients can use LillyDirect self-pay — you just can't run it through your government plan or use a savings card, and Lilly's cash terms ask that you not seek reimbursement.
If you'd rather get help through a telehealth provider, Ro carries FDA-approved Zepbound. Ro's membership is $39 for the first month, then $149/month — or as low as $74/month on an annual plan paid upfront. Important: that membership covers visits and insurance support; the medication cost is separate (your copay if covered, or the cash/savings price if not).
If insurance might work, a free coverage check is the cheapest first move. If it won't, don't assume retail is your only option.
Check your Zepbound coverage and cash-pay options with Ro → (sponsored affiliate link, opens in a new tab)Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
What if you're denied — or your plan calls it “weight loss”?
Find your denial language on the left and do what's on the right:
| What the denial says | What it usually means | Your best next move |
|---|---|---|
| "Weight-loss medications are excluded" | Filed as weight loss, not OSA | Ask if there's a separate OSA prior-auth or exception path |
| "Not medically necessary" | Missing clinical proof | Resubmit with sleep study, AHI, BMI, and a medical-necessity letter |
| "Prior authorization required" | Not a denial yet | Have your prescriber submit the full PA packet |
| "Not on formulary" | Drug isn't on your list | Request a formulary exception tied to the OSA diagnosis |
| "Step therapy required" | Plan wants another drug tried first | Ask what's required, and whether your OSA diagnosis qualifies for an exception |
| "Missing information" | A document gap | Send the sleep study, BMI, diagnosis, and CPAP notes |
| "Plan exclusion" | A harder wall | Confirm whether the exclusion covers the OSA indication or only weight loss |
What to attach to an appeal:
Your denial letter, your sleep study, BMI documentation, your prescriber's letter of medical necessity, your OSA diagnosis and severity, CPAP notes if relevant, and any formulary-exception form your plan uses.
Your first appeal doesn't need to be an aggressive legal letter. Clean and factual wins:
“This request is for FDA-approved treatment of moderate-to-severe obstructive sleep apnea in an adult with obesity — not weight loss alone. Attached are the sleep study results, BMI documentation, diagnosis notes, and prescriber rationale required under the plan's prior authorization criteria. Among GLP-1 medications, Zepbound is the only one FDA-approved for this condition.”
What if your employer or pharmacy plan excludes GLP-1s?
Call your HR or benefits team and ask, in this order:
- “Is Zepbound covered under our pharmacy benefit?”
- “Is there a separate coverage path for FDA-approved sleep apnea?”
- “Is the exclusion for weight-loss medications only, or for all uses of Zepbound?”
- “Is prior authorization or a formulary exception available?”
- “Can you send me the written policy or the basis for any denial?”
If the answer is a true, no-exceptions exclusion, don't burn weeks on a losing appeal. Move to self-pay (LillyDirect at about $299–$449/month), or take our quiz to map the cheapest path for your situation. The right person for an appeal is someone with a coverable diagnosis and a fixable filing problem — not someone fighting a brick wall.
Is Zepbound a replacement for CPAP?
CPAP is still a frontline OSA treatment, and many people benefit from it. In the trials, tirzepatide helped people both with and without a CPAP machine. Some people may end up using both for a while. Do not stop CPAP or change your sleep apnea treatment without your clinician's direction — and there's an insurance reason to keep good CPAP records, too: some plans ask about your CPAP use (or why you can't tolerate it) as part of approving Zepbound.
What we won't say, because none of it is true or safe: that Zepbound “replaces CPAP,” that every OSA patient qualifies, or that your apnea is guaranteed to resolve.
What people keep running into
One pattern shows up over and over: people who clearly meet the criteria, with a sleep study in hand, still get denied — because the request was processed as “weight loss” rather than sleep apnea. The frustration is real, and it's usually fixable with the right refiling under the OSA indication.
For a sense of scale on coverage itself, here's a real data point worth keeping in perspective: Ro's 2025 GLP-1 Insurance Coverage Checker report found that 43% of users had coverage for a GLP-1 (for weight loss), and half of those covered paid $50 a month or less. (Source: Ro.) Don't read that as “43% of plans cover Zepbound for sleep apnea” — your OSA result still depends on your plan, your formulary, your diagnosis, and your prior authorization. But it does say what the horror stories don't: coverage is more common than you'd think. You just have to find out where you stand.
Quick reminder: insurance approval is about coverage, not about whether Zepbound is right for your body — only a licensed clinician can decide that. Zepbound carries a boxed warning about thyroid C-cell tumors and is not for people with a personal or family history of medullary thyroid cancer or MEN 2. The FDA also lists warnings for severe stomach and intestinal problems, acute pancreatitis, gallbladder problems, low blood sugar (especially with insulin or certain diabetes drugs), acute kidney injury, serious allergic reactions, worsening diabetic eye disease in people with type 2 diabetes, suicidal thoughts or behavior, and a risk of breathing in stomach contents during surgery or deep sedation.
And to be crystal clear — compounded tirzepatide is not Zepbound, it isn't FDA-approved, and it is not the subject of this insurance guide. (Source: FDA label.)
What we actually verified
We separate three kinds of facts: official medical and regulatory facts (the FDA approval, CMS Medicare rules, published trial results), verified commercial facts (current prices and policies, checked against payer and manufacturer sources), and our editorial judgment (clearly labeled as opinion).
| Claim | Status | Who it applies to |
|---|---|---|
| Zepbound is FDA-approved for moderate-to-severe OSA in adults with obesity (Dec 20, 2024) | Verified (FDA) | Everyone |
| Some plans cover the OSA indication even when they exclude weight-loss drugs | Verified (UnitedHealthcare and others) | Commercial plans with an OSA path |
| Every plan must cover Zepbound for OSA | False -- coverage is plan-specific | -- |
| The Medicare $50 GLP-1 Bridge is the path for sleep apnea | False -- OSA goes through regular Part D (CMS) | Medicare Part D |
| Savings card can lower cost to about $25/month | Verified, with eligibility limits (Eli Lilly) | Eligible commercial coverage only |
| Medicare/Medicaid patients can use the savings card | False -- government insurance is excluded | -- |
| LillyDirect self-pay: $299 / $399 / $449 by dose | Verified, terms apply (Eli Lilly) | Cash-pay |
| CVS Caremark adds Zepbound back to commercial lists Oct 1, 2026 | Verified (Reuters; Managed Healthcare Executive) | CVS Caremark commercial members |
| Your exact out-of-pocket cost | Depends on your plan -- verify directly | You |
Frequently asked questions
About insurance coverage for Zepbound for sleep apnea.
Does insurance cover Zepbound for sleep apnea?
Some plans do. The strongest path is documented moderate-to-severe obstructive sleep apnea in an adult with obesity, with prior authorization filed under the OSA indication and backed by a sleep study and BMI documentation. Coverage is never automatic and almost always needs prior authorization.
Does Medicare cover Zepbound for sleep apnea?
Medicare Part D can cover Zepbound for OSA through your regular plan's formulary and prior-authorization process. According to CMS, a Zepbound prescription for sleep apnea does not go through the Medicare GLP-1 Bridge -- the Bridge is for weight loss, while OSA is already a Part D-coverable use.
Is the Medicare $50 GLP-1 Bridge the right path for Zepbound sleep apnea?
No. The Bridge ($50/month, July 1, 2026 through December 31, 2027) covers GLP-1s for weight loss. When Zepbound is prescribed for obstructive sleep apnea, it runs through your regular Part D coverage instead.
Does Medicaid cover Zepbound for sleep apnea?
It is state-by-state. Medicaid coverage of GLP-1s for obesity is limited, but because Medicaid generally covers FDA-approved drugs for their approved uses, the sleep apnea indication may be treated differently from weight loss. Check your state's Medicaid formulary and prior-authorization rules before assuming yes or no.
What sleep apnea severity do insurers usually require?
Most OSA criteria require moderate-to-severe sleep apnea documented by a sleep study, commonly an AHI (or REI/RDI) of at least 15 events per hour. Exact wording varies by plan, so check your own policy.
What BMI do I usually need for Zepbound sleep apnea coverage?
For the sleep apnea path, plans like UnitedHealthcare, CVS Caremark, and Aetna use a BMI of 30 or higher. The BMI-27-plus-comorbidity option belongs to the weight-management path, not the OSA-specific one.
Why was I denied as a weight-loss drug if I have sleep apnea?
The request was likely filed as weight loss rather than under the sleep apnea indication, and your plan excludes weight-loss meds. With a documented moderate-to-severe OSA diagnosis, ask your prescriber to refile under the OSA indication, or request a formulary exception or appeal.
Can I use the Zepbound savings card with Medicare?
Generally no. The manufacturer savings card excludes people with government insurance, including Medicare, Medicaid, TRICARE, and VA coverage.
How much does Zepbound cost without coverage?
Self-pay through LillyDirect runs about $299 (2.5 mg), $399 (5 mg), and $449 (7.5-15 mg) per month, versus roughly $1,086 retail for pens. Terms and prices change, so confirm current pricing with Eli Lilly.
Should I stop CPAP if I start Zepbound?
No one should stop CPAP or change sleep apnea treatment without a clinician's direction. Zepbound may be part of an OSA treatment plan for eligible adults with obesity, but that decision belongs with your sleep doctor.
Can I substitute compounded tirzepatide to get around coverage?
No. This page is about insurance coverage for FDA-approved Zepbound. Compounded tirzepatide is not Zepbound, is not FDA-approved, and is not the same coverage path.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz — no sign-up required. It points you to the right lane: commercial prior auth, Medicare Part D, the Bridge, state Medicaid, self-pay, or a provider that handles the paperwork for you.
Get your personalized GLP-1 action plan →